Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma L Culver

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
The New England Journal of Medicine|November 14, 2024
Inebilizumab for Treatment of IgG4-Related DiseaseJohn H Stone, Arezou Khosroshahi, Wen Zhang, et al.
Gut|December 13, 2012
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysisPhil A Hart, Terumi Kamisawa, William R Brugge, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitisTim E Middelburg, Laura Cristoferi, Willemijn Ponsioen, et al.
Arthritis Care & Research|February 20, 2018
An International Multispecialty Validation Study of the IgG4-Related Disease Responder IndexZachary S Wallace, Arezou Khosroshahi, Mollie D Carruthers, et al.
The New England Journal of Medicine|June 3, 2026
Obexelimab for the Treatment of IgG4-Related DiseaseEmanuel Della-Torre, Matthew C Baker, Wen Zhang, et al.
United European Gastroenterology Journal|June 20, 2020
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendationsJ-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
The New England Journal of Medicine|November 14, 2024
Inebilizumab for Treatment of IgG4-Related DiseaseJohn H Stone, Arezou Khosroshahi, Wen Zhang, et al.
Gut|December 13, 2012
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysisPhil A Hart, Terumi Kamisawa, William R Brugge, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitisTim E Middelburg, Laura Cristoferi, Willemijn Ponsioen, et al.
Arthritis Care & Research|February 20, 2018
An International Multispecialty Validation Study of the IgG4-Related Disease Responder IndexZachary S Wallace, Arezou Khosroshahi, Mollie D Carruthers, et al.
The New England Journal of Medicine|June 3, 2026
Obexelimab for the Treatment of IgG4-Related DiseaseEmanuel Della-Torre, Matthew C Baker, Wen Zhang, et al.
United European Gastroenterology Journal|June 20, 2020
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendationsJ-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, et al.
Pageof 6